Latest Regulatory Change News

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.

G8 Education has revised down its full-year earnings forecast due to ongoing occupancy challenges and increased regulatory investments, signaling continued sector pressures.

Westpac Banking Corporation reported a solid $6.9 billion net profit for FY25, underpinned by strong deposit growth and ongoing digital transformation, while advancing ambitious sustainability targets.

Locate Technologies has dispatched its Scheme Booklet to shareholders, outlining the proposed acquisition by Locate NZ and urging a vote in favour at the upcoming virtual meeting.

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

Aeris Resources has announced a significant $90 million equity raise through a placement and share purchase plan, aiming to strengthen its balance sheet and fund key growth projects. The raise comes with a discount to recent share prices and supports the company’s strategic expansion and operational improvements.

Humm Group reports a 14% decline in new loan originations for 1Q26, driven by a steep 61% fall in Australian Point of Sale volumes following regulatory changes and technology setbacks. However, international growth and asset expansion provide some offset.

Challenger Limited reported a robust 9% rise in normalised net profit after tax to $456 million for FY25, alongside an 11% dividend increase, while welcoming APRA's capital reforms that promise to boost its financial resilience and growth in retirement income products.

Pivotal Metals Limited has announced a C$2.6 million flow-through share offer targeting Canadian investors, aimed at funding critical minerals exploration in Quebec. The offer complements a concurrent institutional placement, underscoring the company’s aggressive growth strategy amid significant operational risks.

Challenger Limited has welcomed APRA’s proposed capital standards for longevity products, highlighting their potential to reduce capital requirements and stimulate growth in Australia’s retirement income sector.

PT Aneka Tambang Tbk (ANTAM) reports robust nine-month 2025 financial results with significant profit growth, while navigating complex legal disputes and evolving mining regulations.

Cann Group Limited announces a transformative $9 million capital raise alongside a major debt restructure, positioning the medicinal cannabis pioneer for profitability in FY26.